Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil for Endocrine Therapy-Induced Alopecia in Breast Cancer
NCT05417308Phase 1Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of minoxidil in alopecia, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoint: Proportion of days assigned medication was taken/applied at 12 months. Started Mar 2023; status: recruiting.
02
Drugs
minoxidil
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT05417308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05417308.